Table 4 Percentage within each quartile for each antibody type and for the ranked antibody group that developed a clinically significant infection
| Â | Q1 | Q2 | Q3 | Q4 | Â |
|---|---|---|---|---|---|
Number | 15 | 15 | 15 | 15 | Â |
Teichoic acid | 33.3% | 26.7% | 13.3% | 20% | p = 0.682 |
Alpha-toxin | 40% | 20% | 13.3% | 20% | p = 0.427 |
Staphylococcal enterotoxin A | 13.3% | 20% | 46.7% | 13.3% | p = 1.000 |
EndoCAb | 26.7% | 33.3% | 6.7% | 26.7% | p = 1.000 |
4-way rank | 33% | 33.3% | 26.7% | 0% | p = 0.042 |